The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| OGN | -49.38% | N/A | N/A | -72% |
| S&P | +14.49% | +91.09% | +13.83% | +64% |
Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.
High-yielding stocks may be tantalizing, but they often come with risks.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $1.60B | 1.3% |
| Gross Profit | $857.00M | -7.2% |
| Gross Margin | 53.50% | -4.8% |
| Market Cap | $2.78B | -43.6% |
| Market Cap / Employee | $0.28M | 0.0% |
| Employees | 10K | 0.0% |
| Net Income | $160.00M | -55.4% |
| EBITDA | $450.00M | -2.0% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $672.00M | -11.9% |
| Accounts Receivable | $1.48B | -11.9% |
| Inventory | 1.5K | 7.6% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $8.78B | 0.5% |
| Short Term Debt | $45.00M | 350.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 3.81% | -7.1% |
| Return On Invested Capital | 18.05% | -7.1% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $218.00M | 120.2% |
| Operating Free Cash Flow | $264.00M | 87.2% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 4.48 | 5.15 | 3.60 | 5.55 | 46.30% |
| Price to Book | 7.79 | 8.13 | 4.61 | 3.79 | -88.93% |
| Price to Sales | 0.61 | 0.62 | 0.40 | 0.44 | -43.02% |
| Price to Tangible Book Value | -0.79 | -0.68 | -0.45 | -0.52 | -45.39% |
| Price to Free Cash Flow TTM | 8.30 | 8.11 | 5.87 | 4.50 | -59.18% |
| Enterprise Value to EBITDA | 32.21 | 30.06 | 26.06 | 24.31 | -13.87% |
| Free Cash Flow Yield | 12.0% | 12.3% | 17.0% | 22.2% | 145.00% |
| Return on Equity | 429.9% | 254.2% | 159.6% | 71.6% | - |
| Total Debt | $9.04B | $8.96B | $8.90B | $8.83B | 0.90% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
